- Home
- PLXS vs ACLX Comparison
PLXS vs ACLX Comparison
Compare PLXS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLXS
- ACLX
- Stock Information
- Founded
- PLXS 1979
- ACLX 2015
- Country
- PLXS United States
- ACLX United States
- Employees
- PLXS N/A
- ACLX N/A
- Industry
- PLXS Electrical Products
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- PLXS Technology
- ACLX Health Care
- Exchange
- PLXS Nasdaq
- ACLX Nasdaq
- Market Cap
- PLXS 3.6B
- ACLX 3.5B
- IPO Year
- PLXS 1986
- ACLX 2022
- Fundamental
- Price
- PLXS $134.25
- ACLX $69.02
- Analyst Decision
- PLXS Buy
- ACLX Strong Buy
- Analyst Count
- PLXS 4
- ACLX 14
- Target Price
- PLXS $157.33
- ACLX $111.42
- AVG Volume (30 Days)
- PLXS 168.1K
- ACLX 533.5K
- Earning Date
- PLXS 07-23-2025
- ACLX 08-07-2025
- Dividend Yield
- PLXS N/A
- ACLX N/A
- EPS Growth
- PLXS 41.85
- ACLX N/A
- EPS
- PLXS 5.14
- ACLX N/A
- Revenue
- PLXS $3,967,612,000.00
- ACLX $76,809,000.00
- Revenue This Year
- PLXS $4.62
- ACLX N/A
- Revenue Next Year
- PLXS $9.00
- ACLX $112.68
- P/E Ratio
- PLXS $25.99
- ACLX N/A
- Revenue Growth
- PLXS N/A
- ACLX N/A
- 52 Week Low
- PLXS $103.43
- ACLX $47.86
- 52 Week High
- PLXS $172.89
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- PLXS 49.52
- ACLX 62.53
- Support Level
- PLXS $134.48
- ACLX $67.46
- Resistance Level
- PLXS $141.34
- ACLX $69.63
- Average True Range (ATR)
- PLXS 2.93
- ACLX 2.10
- MACD
- PLXS -0.24
- ACLX 0.36
- Stochastic Oscillator
- PLXS 36.36
- ACLX 90.76
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.